WHAT YOU NEED TO KNOW With rising prescription drug prices at top of mind for many Americans, it’s continuing to receive attention on the campaign trail.  This week former New York City Mayor Mike Bloomberg released a new drug pricing plan that would tackle one of the biggest problems by reforming our nation’s broken patent system. Bloomberg’s plan limits […]

Continue Reading

Presidential Candidate Mike Bloomberg Proposes New Patent Reform Plan to Implement Long Overdue Patent Reforms IN CASE YOU MISSED IT: The Coalition Against Patent Abuse, a diverse coalition of healthcare providers, consumer groups, patient advocacy organizations, free-market advocates and others released the following statement today regarding presidential candidate Mike Bloomberg’s new drug pricing plan that would […]

Continue Reading

IN CASE YOU MISSED IT: While American patients struggle to pay for their prescription drugs, Big Pharma is spending unprecedented amounts on efforts to prevent more affordable medications and treatments. Recent reporting from STAT News and Politico Pro found that in 2019, the trade group PhRMA spent over $28.9 million to lobby Congress. This influx of […]

Continue Reading

IN CASE YOU MISSED IT: On Friday, Roll Call published the below op-ed by Matthew Lane, executive director of the Coalition Against Patent Abuse. In this thought-provoking piece, Lane praises the bipartisan efforts of last year, notably those of Senators Richard Blumenthal (D-CT) and John Cornyn (R-TX), to rein in Big Pharma and lower prescription drug prices. […]

Continue Reading

WHAT YOU NEED TO KNOW Today, Roll Call published an op-ed by Matthew Lane, executive director of the Coalition Against Patent Abuse praising the ongoing bipartisan efforts to rein in Big Pharma’s abuse of the American patent system. “Finding common ground isn’t easy in today’s divided Washington. We are even seeing it in the broader drug pricing debate […]

Continue Reading

IN CASE YOU MISSED IT: This morning, The Washington Post published a must-read analysis highlighting how AbbVie’s use of tactics like patent thickets have allowed them to continue raising the price of their drug AbbVie while also preventing more affordable generic alternatives from coming to market. Today’s analysis follows recent reporting from Axios that AbbVie has begun 2020 by raising the price […]

Continue Reading

IN CASE YOU MISSED IT: Axios reports that as of Friday, major pharmaceutical companies raised prices on over 440 drugs with an average price hike of 5 percent. Additional price increases are expected thought January. Through their use of manipulative tactics like evergreening and patent thicketing, Big Pharma has been able to extend their drug monopolies and prevent competitive drug […]

Continue Reading